Therefore, CD24 formed the focus of further experimentation to look for its ability to mark a cisplatin resistant stem population and the correlation of its expression with the cisplatin IC-50 values in these HNSCC lines. The gene discussed is CD24; the disease is head and neck squamous cell carcinoma.